Gwen A. Huitt, MD, MS - Addressing Challenges in the Treatment of Nontuberculous Mycobacterial Lung Disease: Managing Adverse Effects to Keep Patients on Therapy
Manage episode 282420052 series 2857008
Player FM과 저희 커뮤니티의 PeerView, 24 West 40th Street, Suite 950, New York, NY 10018, PVI, and PeerView Institute for Medical Education 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Go online to PeerView.com/SVG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in NTM-LD discusses diagnosing and treating a patient with NTM-LD, with the goal of maintaining treatment adherence. Upon completion of this activity, participants should be better able to: Describe the burden of treatment associated with nontuberculous mycobacterial lung disease (NTM-LD), especially adverse events that may lead to patient discontinuation of therapy, Discuss the latest evidence-based recommendations for the treatment of NTM-LD, including airway clearance, medication optimization, susceptibility testing, repeated cultures, and duration of treatment, Develop treatment plans for patients with NTM-LD based on the latest ATS/IDSA guidelines, disease severity, patient needs and preferences, and the latest clinical evidence on efficacy and safety, Apply strategies to manage adverse events associated with treatment of NTM-LD in order to maintain patient adherence to therapy and improve outcomes.